These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3017033)

  • 1. Effects of angiotensin II infusion on the early morning surge of ACTH and o-CRH-provoked ACTH secretion in normal man.
    Haller H; Hensen J; Bähr V; Oelkers W
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):150-6. PubMed ID: 3017033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs.
    Brooks VL; Daneshvar L; Reid IA
    Endocrinology; 1988 Jan; 122(1):97-104. PubMed ID: 2826116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans.
    Baram TZ; Mitchell WG; Haden E
    Mol Psychiatry; 1996 Sep; 1(4):320-4. PubMed ID: 9118358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of peripherally infused angiotensin II on the human hypothalamic-pituitary-adrenal axis.
    Calogero AE; Fornito MC; Aliffi A; Vicari E; Moncada ML; Mantero F; Polosa P; D'Agata R
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):183-6. PubMed ID: 1645236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
    Oelkers W; Bähr V
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to corticotropin-releasing hormone during pregnancy in the baboon.
    Goland RS; Stark RI; Wardlaw SL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):925-9. PubMed ID: 2156891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.
    Kling MA; Demitrack MA; Whitfield HJ; Kalogeras KT; Listwak SJ; DeBellis MD; Chrousos GP; Gold PW; Brandt HA
    Neuroendocrinology; 1993 Jun; 57(6):1082-91. PubMed ID: 8232766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man.
    Oelkers W; Schöneshöfer M; Schultze G; Brown JJ; Fraser R; Morton JJ; Lever AF; Robertson JI
    Circ Res; 1975 Jun; 36(6 Suppl 1):49-56. PubMed ID: 165908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
    Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II on plasma ACTH in patients with Addison's disease.
    Haller H; Bähr V; Exner P; Oelkers W
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):451-5. PubMed ID: 3004086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
    Oelkers W; Boelke T; Bähr V
    J Clin Endocrinol Metab; 1988 Jan; 66(1):181-6. PubMed ID: 2826525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.
    Ur E; Faria M; Tsagarakis S; Anderson JV; Besser GM; Grossman A
    J Endocrinol; 1991 Oct; 131(1):163-7. PubMed ID: 1660514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.